Overview
- Worldpanel by Numerator's June 2026 data, reported June 10, found GLP‑1 use nearly tripled in two years to 6.3% of households, about 1.9 million adults.
- The firm estimates households with a GLP‑1 user bought about 299 million fewer grocery items and spent a combined £780 million less over a year, roughly £418 less per user household.
- Users report smaller appetites and fewer cravings, producing steep falls in snack and confectionery sales—notably chocolate and crisps—while mouthwash, chewing gum and nutrient‑dense products have risen.
- Cost is a major constraint: around four in ten users say they stopped treatment because of expense, and roughly 77% of current users are women with about 68% using the drugs mainly to lose weight.
- Retailers and restaurants are already adjusting ranges and menus in response and public‑health groups warn that wider policy action on the food environment is still needed; approval of oral GLP‑1 forms in other markets could accelerate uptake, a development cited as possible but not yet confirmed for the UK.